Revimine en es it fr

Revimine Brand names, Revimine Analogs

Revimine Brand Names Mixture

  • No information avaliable

Revimine Chemical_Formula


Revimine RX_link

Revimine fda sheet

Revimine msds (material safety sheet)

Revimine MSDS

Revimine Synthesis Reference

No information avaliable

Revimine Molecular Weight

153.178 g/mol

Revimine Melting Point

82.5 oC

Revimine H2O Solubility

600 g/L

Revimine State


Revimine LogP


Revimine Dosage Forms


Revimine Indication

For the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure

Revimine Pharmacology

Dopamine is a natural catecholamine formed by the decarboxylation of 3,4-dihydroxyphenylalanine (DOPA). It is a precursor to norepinephrine in noradrenergic nerves and is also a neurotransmitter in certain areas of the central nervous system, especially in the nigrostriatal tract, and in a few peripheral sympathetic nerves. Dopamine produces positive chronotropic and inotropic effects on the myocardium, resulting in increased heart rate and cardiac contractility. This is accomplished directly by exerting an agonist action on beta-adrenoceptors and indirectly by causing release of norepinephrine from storage sites in sympathetic nerve endings.

Revimine Absorption

Dopamine is rapidly absorbed from the small intestine.

Revimine side effects and Toxicity

LD50 oral mice = 1460 mg/kg, LD50 oral rats = 1780 mg/kg. Spasm or closing of eyelids, nausea, vomiting, cardiac arrhythmias, involuntary movements of the body including the face, tongue, arms, hand, head, and upper body; hypotension, haemolytic anaemia, urinary retention, duodenal ulcer, sialorrhea, ataxia, abdominal pain, dry mouth, nightmares, tachypnoea, bruxism, confusion, and insomnia.

Revimine Patient Information

No information avaliable

Revimine Organisms Affected

Humans and other mammals